Carfilzomib, a proteasome inhibitor, is present in Adcarfil-60 Injection 1's. It suppresses proteasomes, preventing protein breakdown in MM (multiple myeloma) cells. When proteasome function is stopped within the MM cell, a protein build-up occurs within the MM cell, which destroys the malignant cells.

FAQs

How does Adcarfil-60 Injection 1's work?

Adcarfil-60 Injection 1's contains Carfilzomib, which inhibits proteasomes and thereby prevents protein breakdown in MM (multiple myeloma) cells. When the proteasome action within the MM cell is disturbed, a protein accumulation occurs, destroying the cancerous cells.

Is it safe to father a child while taking Adcarfil-60 Injection 1's?

No, it is unsafe to father a child while taking Adcarfil-60 Injection 1's. It is recommended for sexually active men to use condoms while on treatment and for at least several months after their last dose of Adcarfil-60 Injection 1's.

Is Adcarfil-60 Injection 1's combines with other medications to treat multiple myeloma?

Based on the medical condition, Adcarfil-60 Injection 1's may be given alone or together with other medicines used to treat multiple myeloma.

What should I do if I experience Infusion-related reactions?

Tell your healthcare professional immediately if you get any signs of an infusion-related reaction during or after the infusion. Your doctor may give other medicines, or the infusion may need to be slowed down or stopped.

Adcarfil-60 Injection 1's causes a drop in blood cell count?

Adcarfil-60 Injection 1's can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment. Tell your healthcare provider if you develop a fever or have signs of bruising or bleeding.